Neelam Panchal

I am currently a Senior Scientist in the Commercialisation of Research (CoR) team at the cell and gene therapy Catapult (CGTC) where I support academics to develop more commercially investible opportunities. My role involves in-depth due diligence and project triaging to identify both scientific and commercial challenges and risks in order to devise mitigation strategies to advance the project.

Prior to my current role, I carried out my PhD and post-doctoral training and UCL Great Ormond Street Institute of Child Health where I gained extensive experience over the last decade in cell and gene therapy in the group of Professors Claire Booth, Bobby Gaspar, and Adrian Thrasher. I focused on developing novel therapeutic approaches using viral vector mediated gene transfer and gene editing to target and treat primary immunodeficiencies (PID).